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Abstract
Rationale—Primary Ciliary Dyskinesia (PCD) is a genetically heterogeneous condition 
characterized by progressive lung disease arising from abnormal cilia function. Approximately 
half of patients have situs inversus. The estimated prevalence of PCD in the UK South Asian 
population is 1:2,265. Early, accurate diagnosis is key to implementing appropriate management 
but clinical diagnostic tests can be equivocal.
Objectives—To determine the importance of genetic screening for PCD in a UK South Asian 
population with a typical clinical phenotype, where standard testing is inconclusive, and assess the 
relationship between gene mutations and diagnostic phenotype.
Methods—Next-generation sequencing was used to screen 86 South Asian patients who had a 
clinical history consistent with PCD. The effect of a CCDC103 p.His154Pro missense variant 
compared to other dynein arm-associated gene mutations on diagnostic/phenotypic variability was 
tested. CCDC103 p.His154Pro variant pathogenicity was assessed by oligomerisation assay.
Results—Sixteen of 86 (19%) carried a homozygous CCDC103 p.His154Pro mutation found to 
disrupt protein oligomerisation. Variable diagnostic test results were obtained including normal 
nasal nitric oxide levels, normal ciliary beat pattern and frequency and a spectrum of partial and 
normal dynein arm retention. Fifteen (94%) patients or their sibling(s) had situs inversus 
suggesting CCDC103 p.His154Pro patients without situs inversus are missed.
Conclusions—The CCDC103 p.His154Pro mutation is commoner than previously thought in 
the South Asian community and causes PCD that can be difficult to diagnose using pathology-
based clinical tests. Genetic testing is important where there is a strong clinical phenotype with 
inconclusive standard diagnostic tests.
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INTRODUCTION
Primary ciliary dyskinesia (PCD; OMIM: 244400) is an inherited disorder affecting motile 
cilia. Patients usually present with a history of neonatal respiratory distress and suffer from 
lifelong symptoms of chronic wet cough and rhinitis. Recurrent chest infections ultimately 
lead to bronchiectasis and a progressive decline in lung function.1 Approximately half of 
patients have situs inversus and other situs abnormalities, due to ciliary dysmotility in the 
embryonic node.2 Fertility can also be affected by defective cilia in the fallopian tubes and 
non-motile sperm tail flagella.
The estimated prevalence of PCD in the UK is 1:15,000, but as high as 1:2,265 in the UK 
South Asian population.13 Early diagnosis is important to maintain lung function, and 
appropriately treat symptoms to reduce morbidity and mortality.4 Diagnosis can be complex 
and requires a combination of tests for cilia functional and ultrastructural defects.56 PCD is 
caused by mutations in genes encoding proteins conferring structural stability to the cilia and 
governing ciliogenesis. It is genetically heterogeneous with >200 individual mutations in 
more than 30 genes known to cause PCD, accounting for approximately 65% of cases.17–11 
UKGTN-approved tests are offered in two centres (http://www.labs.gosh.nhs.uk/media/
764464/ciliopathies_v8.pdf).12
CCDC103 mutations were first reported, in 2012, in patients with dynein arm loss and a 
typical clinical phenotype13. CCDC103 is an oligomeric protein of the cilia thought to 
participate in microtubule stabilization that facilitates dynein arm attachment and ciliary 
motility.13 A missense variant, p.His154Pro (rs145457535), was previously described as a 
hypomorphic mutation since mutant p.His154Pro CCDC103 induced intermediate partially 
rescued disease phenotypes when expressed in a zebrafish CCDC103-null model, suggesting 
some retained protein function.13 In cilia from p.His154Pro patients, including from a South 
Asian family, some cilia showed a partial dynein arm defect with the outer dynein arms 
(ODA) at least partially assembled, compared to loss-of-function CCDC103 mutations 
causing complete ODA loss. In agreement with this, loss-of-function CCDC103 mutation 
patients had largely static cilia, whilst patients carrying a homozygous p.His154Pro mutation 
exhibit a mixed (static and motile) ciliary beat pattern.13
We conducted genetic screening of 86 PCD patients of South Asian (mostly Pakistani) 
origin, detecting significant numbers (19%) were homozygous for CCDC103 p.His154Pro 
variant. Amongst these, many were at high risk of being mis-diagnosed without genetic 
testing, due to normal diagnostic results obtained in PCD investigations. Using electron 
microscopy and protein biochemistry we have sought to further determine the pathogenic 
nature of the p.His154Pro mutation.
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METHODS
Patient selection
Eighty-six patients of South Asian (primarily Pakistan) descent with clinical signs and 
symptoms of PCD were identified from the UK National PCD Diagnostic and Management 
Services at Leeds and Bradford, The Royal Brompton Hospital, London, University Hospital 
Southampton, Birmingham Children’ s Hospital and Leicester Royal Infirmary.114
Genotyping
All participants gave written informed consent to take part in this study. The protocol was 
approved by the London Bloomsbury Research Ethics Committee (08/H0713/82). High 
throughput screening used next-generation sequencing, either whole exome sequencing 
(WES) or targeted gene panel sequencing. Sequencing and variant identification methods are 
published for WES,1215 or used custom gene panels (Illumina TruSeq Custom Amplicon or 
Agilent SureSelect Focused Exome (proprietary product) and SureSelectXT custom panel 
design systems) and a standardised variant calling pipeline.16 Sanger sequencing was used 
for variant confirmation, familial segregations and the replication study.
Comparator group
The comparator patient group consisted of 16 of the 86 individuals tested. This group was 
closely age and gender matched to the CCDC103 p.His154Pro group, all had a dynein arm 
defect on electron microscopy, but all were proven negative for CCDC103 p.His154Pro 
mutation.
FEV1 measurements
Spirometry was performed according to American Thoracic Society/European Respiratory 
Society recommendations.17 Forced expiratory volume in 1 second (FEV1) z-scores were 
calculated using the Global Lungs Initiative parameters.18
Diagnostic tests
Screening and diagnostic testing was performed according to the PCD National Service 
protocols. Investigations included nNO, nasal brushing analysed by HSVM for ciliary beat 
frequency and pattern19 and quantitative electron microscopy for ciliary ultrastructure.23 
(Full details in OLS). When results were inconclusive or inconsistent, patients were offered 
repeat testing.
Protein biochemistry on recombinant CCDC103 protein
Site-directed mutagenesis (QuikChange kit, Agilent Technologies UK Ltd) was used to 
generate the p.His154Pro mutation in an N-terminal His10 tagged H. sapiens CCDC103 
cDNA synthesized using Escherichia coli codon bias which was subcloned into pET16b 
vector.20 Following transformation into E. coli BL21 (DE3), protein expression was induced 
by addition of 2 mM IPTG for two or more hours. Following sonication, His10-tagged 
proteins were dissolved in 8 M urea, very slowly diluted into 1 litre of 20 mM Tris.Cl pH8.0 
150 mM NaCl then purified by Ni2+-affinity chromatography as described previously. 
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Samples concentrated by ultrafiltration were subject to gel filtration in a calibrated Superose 
6 10/300 column attached to an ÄktaPurifier-10 chromatography workstation.20
Statistical analysis
No power calculation was performed as the study size was opportunistic. The CCDC103 
p.His154Pro group and the comparator group were closely matched for age and gender. Data 
was not normally distributed and therefore groups were compared using non-parametric 
statistical tests. P<0.05 was considered statistically significant.
RESULTS
A PCD-causing mutation CCDC103 p.His154Pro is prevalent in UK individuals of South 
Asian origin with a clinical phenotype of PCD
Genetic screening using next generation sequencing (either WES or gene panel) revealed 16 
patients (19% of a total of 86 patients of South Asian descent) from 12 independent families. 
All were of consanguineous origin and homozygous for a previously published single base 
change (c.461A>C) mutation in CCDC103 that results in the amino acid substitution 
p.His154Pro (Table 1)
In a small predictive study within this investigation, we specifically screened a subset of 
twelve ungenotyped South Asian PCD patients with reported ODA defects or normal 
ultrastructure for the CCDC103 p.His154Pro variant by Sanger sequencing. This detected 
one case (8%) carrying the mutation in homozygous form.
Whole exome sequence data obtained from 1,542 unaffected parents with similar ethnic 
backgrounds participating in the Born-in-Bradford cohort (UK South Asian, primarily 
Pakistani heritage)21 revealed six heterozygous carriers of the CCDC103 p.His154Pro 
variant (E. Sheridan, unpublished data). The ExAc database22 containing exome sequencing 
data from 60,706 unrelated non-PCD individuals records an allele frequency for 
p.His154Pro three times as high in 8,256 South Asian individuals (0.003) compared to 
33,345 North Europeans (0.001). No p.His154Pro homozygote individuals were present in 
the entire Born-in-Bradford or ExAc cohorts.
Amongst the sixteen CCDC103 p.His154Pro homozygote PCD patients identified, normal 
diagnostic test results were apparent as highlighted in Table 1. Although PCD was strongly 
suspected in all cases, five of the sixteen patients (case 9 and 13-16 in Table 1) did not 
receive a definitive disease diagnosis until their genotype was confirmed. Strikingly in the 
case of patient 15, this individual had been deemed to not have PCD and was discharged 
from respiratory care. She was re-tested due to her situs inversus and the finding that her 
brother, who remained under clinical suspicion, had this CCDC103 mutation. Thirteen of the 
16 CCDC103 p.His154Pro patients (81%) have situs inversus, two have a sibling with situs 
inversus and only one child did not have a family history of situs inversus. Situs inversus 
affects approximately 50% patients with PCD with dynein arm defects2 and affected 56% of 
the comparator group in this study (Table 2). 30% of the comparator group had no family 
history of situs inversus.
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Despite these findings, FEV1 measurements showed that impact on lung function was 
similar in the group of 16 p.His154Pro patients compared to a comparator group (Table 1, 
Figure 1). The comparator group of 16 South Asian individuals with PCD all had dynein 
arm deficiency, but due to different genetic causes since this group comprised 3 DNAAF1, 2 
DNAAF3, 2 DNAH5, 3 LRRC6 and 2 ZMYND10 cases whilst 4 were genetically 
undefined. The mean difference for clinical measures between the CCDC103 p.His154Pro 
and comparator groups is presented in Table 2, showing an equivalent age and gender 
composition.
PCD caused by the CCDC103 p.His154Pro mutation can be associated with normal nasal 
nitric oxide (nNO) results
We proceeded to retrospectively analyse clinical phenotypes of the sixteen affected South 
Asian patients carrying the homozygous p.His154Pro missense mutation in more detail, as 
presented in Table 1. Of the 16 p.His154Pro patients tested, seven (43%) had normal nNO 
levels, above 77nl/min which is a recommended diagnostic cut off.23 Of these 7 patients, 
most (patients 5, 7, 11, 12 and 13) were subject to repeat measurements at subsequent clinic 
appointments. Patient 12 displayed persistent values within the normal range up to 5 years 
from the first measurement. Mean nNO was significantly higher than the low levels 
consistently detected in the comparator PCD patient group (Table 2).
PCD caused by the CCDC103 p.His154Pro mutation can be associated with areas of 
normal ciliary beat frequency on high speed video light microscopy
High-speed video microscopy revealed that amongst the 16 homozygous p.His154Pro 
individuals, nine (56%) had ciliary beat frequencies within the normal range of 8.5-16.8Hz 
(average 11.6Hz)19 (Table 1). The other seven p.His154Pro patients (patients 1-6 and 13) 
had a reduced beat frequency, on average 3.9Hz (range 0-7.7Hz), which is more in keeping 
with typical results found for PCD patients and more specifically found for CCDC103 
patients expressing loss-of-function alleles.1324 The comparator group of PCD patients 
displayed a reduced ciliary beat frequency, on average 1.3Hz (Table 2), which is similar to 
the reported reduced ciliary beating seen in published PCD cases associated with other 
causes of dynein arm loss. In half the p.His154Pro patients the beat pattern of cilia was 
completely or largely normal in some strips of epithelium (patients 5-7, 9, 10, 12, 15, 16, 
Table 1) whilst static, slow or dyskinetic in others. Some His154Pro patients (7, 10, 16) 
demonstrated a full beat pattern and almost immotile cilia together within the same sample 
(Supplementary videos 1-3). Therefore the motility in p.His154Pro individuals was variable, 
compared to the fully motile cilia of healthy controls (Supplementary video 4) and the 
completely static cilia seen in patients with LRCC6 and ZMYND10 defects from the 
comparator group (Supplementary video 5).
PCD caused by the CCDC103 p.His154Pro mutation can be associated with normal 
ultrastructural appearance by electron microscopy
Of the 16 CCDC103 p.His154Pro individuals, seven patients (44%) (cases 1-7 in Table 1) 
had a defect of the ciliary inner and outer dynein arms demonstrated by transmission 
electron microscopy (Table 1). The other nine p.His154Pro individuals (cases 8-16) had 
TEM that either showed an absence of the inner dynein arm, or that was considered normal 
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or inconclusive despite extensive interrogation. The spectrum of ultrastructural defects found 
in p.His154Pro individuals is illustrated with representative examples in Figure 2. Overall, 
the inner dynein arm appeared to be the most affected structure in these cases, with 
significant retention of outer dynein arms. Quantification of these dynein arm defects is 
shown in Figure 3. Published normal range counts from >200 non-PCD respiratory controls 
are also shown for comparison (Figure 3, grey box). Notably, samples from four CCDC103 
p.His154Pro patients were within this normal range. When a partial defect of the outer 
dynein arm was seen, an assessment of proximity to the epithelial cell surface - as judged by 
the presence of neighboring microvilli - showed that ODA loss typically occurred at the 
distal end towards the tip of the cilia in the sample.
A summary shown in Table 2 highlights that the majority of CCDC103 p.His154Pro cases 
clearly differed from the non-CCDC103 comparator group, which have a near complete 
absence of both dynein arms. This is highly significant in terms of outer dynein arm loss 
(p<0.05), with only 27% ODA absence in the CCDC103 p.His154Pro cilia compared to 89% 
in the comparator group. Inner dynein arms were also clearly more retained in CCDC103 
p.His154Pro cilia, but this difference did not reach statistical significance. The overall 
relative lack of disturbance to dynein arm structures means that CCDC103 p.His154Pro 
TEM overlaps with that of non PCD controls.
Biochemical analysis of CCDC103 p.His154Pro mutation reveals an abrogation of its 
oligomerisation capacity
We conducted gel filtration of purified CCDC103 p.His154Pro protein compared to the 
normal protein using previously established methods,20 to assess the functional viability of 
the mutant form of the protein. The p.His154Pro variant appears to be a highly disruptive 
mutation that reduces protein folding ability and almost completely abolishes the ability of 
CCDC103 to oligomerize beyond a dimer, as shown in the chromatogram (Figure 4).
DISCUSSION
We report from genetic screening of a PCD cohort ascertained through UK National PCD 
Services that the CCDC103 p.His154Pro mutation accounts for approximately one fifth of 
cases in the South Asian PCD community. Therefore a significant risk of disease arises from 
the presence of this important common mutation, to the extent that a predictive screen for 
p.His154Pro in the highly consanguineous South Asian community picked up one case out 
of 12 where the patient selection was based purely on ethnic origin and a TEM result.
Despite the relatively high prevalence of CCDC103 p.His154Pro, this mutation is not the 
sole cause of the increased incidence of PCD reported in the British South Asian 
community.3 Our screen also revealed patients in the group of 86 screened that carry causal 
mutations in an assortment of other genes including CCDC40, DNAAF1, DNAAF3, 
HEATR2, LRRC6, ZMYND10 and RSPH4A. Conversely, the CCDC103 p.His154Pro 
defect is not exclusive to the UK Asian community and has also been detected in a patient 
from an Irish travelling family25 as well as in two North European origin families with PCD 
from our studies (unpublished data).
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This study highlights extensive variability in the diagnostic results from CCDC103 
p.His154Pro mutations. Normal standard diagnostic test results have led to CCDC103 
p.His154Pro patients being discharged from the PCD clinic, and in some cases the diagnosis 
of PCD in a CCDC103 p.His154Pro patient was only finally confirmed following the 
genetic results. Fifteen (94%) patients or their sibling(s) had situs inversus suggesting 
CCDC103 p.His154Pro patients without situs inversus are missed either due to lack of 
referral or due to normal diagnostic tests.
These patients represent an expanded phenotype for PCD, since without genetic results 
many in this group may not have been considered to meet the current UK clinical diagnostic 
criteria for PCD, resulting in uncertainty for the patient and their parents and unnecessary 
further investigation into the cause of their symptoms. One South Asian patient in the 
comparator group had a TEM phenotype similar to that of the CCDC103 p.His154Pro 
group. This individual also had a nNO level of >77nl/min, but a screen for the CCDC103 
mutation was negative (Figure 3). This case, along with other patients in our clinic, suggests 
that there will be other mutations which cause PCD with non-diagnostic results.
Interestingly, functional preservation in CCDC103 p.His154Pro-mutant cilia is not 
apparently accompanied by significantly preserved lung function, since the FEV1 range in 
p.His154Pro patients is equivalent to the comparator group and respiratory capacity is 
equally reduced in these individuals. However, larger numbers of patients and controls 
should be analysed to verify this observation and genotype – phenotype relationships could 
be further investigated with more sensitive tests for staging lung disease such as Lung 
Clearance Index or CT scan. Patients with this mutation could represent an interesting cohort 
for targeted gene therapies due to their prevalence, but also because all the components 
required for normal ciliary beating appear to be present, albeit at variable levels.
The nNO levels within the normal range in CCDC103 p.His154Pro patients highlight the 
importance of considering the full clinical history in conjunction with nNO testing in 
patients with suspected PCD. Clinicians should proceed to further testing in cases with a 
high index of clinical suspicion, using the NO test as part of a multidisciplinary diagnostic 
protocol rather than a stand-alone screening test. This is not the first report of normal nNO 
results in patients with PCD. Some patients with RSPH1 mutations are also reported to have 
levels of NO close to normal and we expect further such cases to be reported as the complex 
genetic landscape of PCD diagnosis is unraveled further.26
The apparently normal/mixed beat pattern found in half of p.His154Pro cases was 
surprisingly high, but is supported by previous work indicating that this represents a 
hypomorphic allele in cilia function tests.13 Awareness of these cases is critical when 
assessing diagnostic samples in the laboratory. Due to the eye being naturally drawn to 
movement it is possible that the observer may inadvertently select beating strips over those 
that are static when scanning the sample at 5-20 times magnification before full analysis 
with high speed video, therefore inadvertently missing this defect when a significant portion 
of the sample has a normal co-ordinated beat. This places an emphasis on diagnostic centres 
to increase awareness and expertise of the operators when assessing nasal biopsies by high-
speed video microscopy. HSVM does not measure the power of the ciliary beating, but in 
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cases with a normal stroke and frequency there could be weakness in the strength of the 
beating that might not be detected by any of the current diagnostic tests.
In this study, TEM diagnosis often revealed a pattern of intermittent IDA and ODA loss in 
CCDC103 p.His154Pro patients which was distinct from cases of dynein arm absence due to 
mutations in other genes such as LRRC6, DNAAF1 and ZYMND10. The distinction was 
most significant for ODA retention with CCDC103 p.His154Pro. Despite analysis of >100 
cilia cross sections, usually sufficient for diagnosis, the loss of dynein was not always 
detected by electron microscopy. However, it has long been accepted that normal 
ultrastructure by electron microscopy cannot exclude PCD.2728 Our study appears to 
confirm in CCDC103 p.His154Pro patients the previous evidence that CCDC103 mutations 
confer a loss of distal ODAs containing DNAH9, not ODAs in the proximal half of the cilia 
closer to the epithelial surface.13
This study contributes strong evidence that CCDC103 p.His154Pro is pathogenic rather than 
a benign polymorphism. It is present at very low frequency in the non-PCD population and 
no CCDC103 p.His154Pro homozygote individuals were detected in large scale screening of 
9,798 South Asian and 33,345 North European controls. Also, segregation analysis in the 16 
families studied here showed an inheritance pattern consistent with recessive disease (data 
not shown). The CCDC103 protein remains poorly characterised but is considered important 
in stabilising microtubules by helping to generate a high-affinity site on the doublets for 
outer arm assembly, either through direct interactions or indirectly, by modifying the 
underlying microtubule lattice.20 Previous studies have shown that CCDC103 usually forms 
dimers and higher order oligomers, and that the microtubule-binding capacity is a property 
of the protein’ s central region which contains a highly conserved RPAP3_C domain that 
functions in protein-protein interactions. The His154 amino acid is contained within the 
conserved RPAP3_C functional domain which spans residues 96-189 of the protein, 
therefore altering His154 might be expected to disrupt function. Our current results reveal 
that the His154Pro form retains the ability to dimerize but shows little oligomer formation, 
suggesting that this property is disrupted by the mutation and that CCDC103 may have two 
distinct self-interaction domains. We hypothesise that gene mutations causing instability or 
depletion of CCDC103 protein may make the attachment of the dynein arms more 
susceptible to physical, infective or inflammatory insult. We cannot determine if the 
presence of normal cilia in our patients is temporal or spatial however, as results appear to 
vary from one biopsy to the next e.g. in case 11, 12, 15 and 16 in Table 1; cell culture and 
repeating investigations may be useful in these cases.
In conclusion, the CCDC103 p.His154Pro variant is prevalent in the UK South Asian 
community and likely to be found in South Asian patients worldwide. Therefore this patient 
group should undergo genetic testing for p.His154Pro, especially if (partial) dynein arm 
absence is suspected. These patients are frequently a diagnostic dilemma, due to 
inconclusive results of multiple clinical diagnostic tests. This study expands the diagnostic 
phenotype which we consider to be PCD, since in some cases pathology-based tests can be 
equivocal as the cilia can beat at least partially in a co-ordinated manner, at the correct speed 
and may appear structurally normal. PCD is widely understood to be an underdiagnosed 
condition and this appears to be the case for CCDC103 p.His154Pro patients, who 
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demonstrate a high level of situs inversus probably indicative of a lack of recognition 
making their diagnosis liable to be missed.29 We anticipate that studies such as this, in 
combination with easier access to high throughput and economically achievable genetic 
screening, should greatly increase disease recognition and understanding. We have 
highlighted the importance of multidisciplinary testing, repeat testing and genotyping in 
patients with a highly suggestive history for PCD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What is the key question?
Can gene sequencing improve diagnosis of the inherited respiratory condition primary 
ciliary dyskinesia in patients with unclear clinical diagnostic investigations?
What is the bottom line?
CCDC103 p.His154Pro missense mutations cause up to 20% PCD cases in UK South 
Asian populations but their diagnosis can be difficult in this group using standard clinical 
diagnostic tests where results are often normal, we therefore propose that genetic analysis 
is an essential part of the diagnostic algorithm to complement standard clinical tests to 
improve diagnostic accuracy.
Why read on?
Patients with primary ciliary dyskinesia may be missed using current pathology-based 
diagnostic protocols that do not include funded genetic screening.
For Twitter: 140 character conclusion
Diagnosis can be difficult in PCD with CCDC103 p.His154Pro mutations and genetic 
testing is essential in the high-risk UK South Asian community.
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Figure 1. Comparison of predicted FEV1 in CCDC103 p.His154Pro cases versus a comparator 
group
The CCDC103 p.His154Pro cases are described in Table 1 and the comparator group are 
South Asian origin CCDC103 p.His154Pro-negative cases with a confirmed absent dynein 
arms defect.
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Figure 2. Transmission electron microscopy of CCDC103 p.His154Pro patients
Representative cilia cross sections show (A) absent outer and partially absent inner dynein 
arms, (B) presence of outer dynein arms only and presence of both inner and outer dynein 
arms within the same micrograph. (C) Inset shows presence of outer but not inner dynein 
arms. Black arrows indicate example outer dynein arms. White arrows indicate inner dynein 
arms. Scale bar, 100 nm.
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Figure 3. Quantitative transmission electron microscopy survey of inner and outer dynein arm 
loss in CCDC103 p.His154Pro patients versus a comparator group
By surveying >100 cross sections in each patient sample we performed quantitative electron 
microscopy to determine the percentage of arm defects in cilia from individuals homozygous 
for the hypomorphic p.His154Pro CCDC103 mutation. Red diamonds and triangles indicate 
results from 16 CCDC103 p.His154Pro homozygote PCD patients, where triangles indicates 
the result of 4 repeat nasal brushings performed on patients marked by a diamond. The 
comparator group of 16 individuals with PCD, indicated by other symbols as shown, 
consists of 3 cases with DNAAF1 mutations (open diamonds), 2 DNAAF3 (black squares), 
2 DNAH5 (dark blue diamonds), 3 LRRC6 (2 as light blue diamonds, 1 contained within the 
filled purple circle), 2 ZMYND10 (contained within the filled purple circle) and 4 cases in 
whom no mutations in known genes could be identified (grey squares). 6 CCDC103 
p.His154Pro samples (27%) of p.His154Pro samples showed complete lack of both outer 
and inner dynein arms comparable to other gene mutations in the graph (purple circle). The 
grey shaded area represents normal range counts from >200 non PCD respiratory controls.30 
Four CCDC103 p.His154Pro patients had counts within this normal range (one is a repeat 
sample (triangle) which showed similar data). Individuals with CCDC103 p.His154Pro 
mutation have a trend towards a distinctive pattern of partial loss of dynein arms that 
diverges from total dynein arm loss in the comparator group.
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Figure 4. CCDC103 p.His154Pro oligomerisation capacity
Chromatograms of wildtype (red trace) and His154Pro (green trace) CCDC103 native 
proteins separated in a calibrated Superose 6 10/300 gel filtration column. The data is 
plotted as absorbance at 280 nm (in mAU) against elution volume (ml). Both proteins show 
strong dimer peaks at ~60 kDa. However, only the wildtype form generates a series of 
higher-order oligomers with an approximate mass of ~250 kDa. Aggregated material (>2 
MDa) eluted in the void volume.
Shoemark et al. Page 17
Thorax. Author manuscript; available in PMC 2019 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Author ManuscriptAuthor ManuscriptAuthor ManuscriptAuthor Manuscript
Shoem
ark et al.
P
age 18
Table 1
Clinical history of CCDC103 p.His154Pro cases summarising diagnostic investigations
Demographics Symptoms Diagnostic test results
ID Sex Age (yrs) Age diag (yrs) Family History FEV1 z-score Main Symptoms Situs Nasal NO (nl/min) CBF (Hz) Ciliary beat pattern
Electron 
microscopy 
(1st 
brushing)
Electron 
microscopy 
(repeat 
brushing)
Genetics: sequencing protocol
1 M 7 7 No −3.45 Chronic cough, developmental delay SI ND 0 Immotile IDA +ODA IDA +ODA CM Watson et al. 2014
2 M 4 1 No −2.25 Nasal discharge SI 1 0.95
Mostly immotile with 
occasional residual 
movement
IDA +ODA IDA +ODA CM Watson et al. 2014
3 M 12 10 No −2.75 Neonatal respiratory distress, nasal discharge SS 11 2.9
Mostly immotile with 
occasional residual 
movement
IDA +ODA IDA +ODA CM Watson et al. 2014
4 M 13 <1 No ND Neonatal respiratory distress, Gilbert syndrome, epilepsy SI 7 5.9
Mostly immotile with 
occasional residual 
movement
IDA +ODA IDA +ODA CM Watson et al. 2014
5 M 13 6 Sib 6 −1.52 Recurrent chest infections SI 87 5.79 Normal ciliary beat pattern 
reduced frequency IDA +ODA IDA +ODA WES
6 F 15 4 Sib 5 −0.61
Recurrent chest infections, 
Eustachian tube dysfunction, nasal 
discharge
SS 43 7.66 Normal ciliary beat pattern 
reduced frequency IDA +ODA IDA +ODA WES
7 F 18 9 No −1.58 Recurrent chest infections, nasal discharge, bilateral glue ear SI 111 10.6
Mixed Sample 1: normal 
ciliary beat pattern sample 
2: Immotile
IDA +ODA IDA +ODA Illumina TruSeq custom gene panel
8 M 9 6 No −0.08 Wet cough, recurrent chest infections, conductive hearing loss SI 57 8.8 Dyskinesia IDA IDA Agilent SureSelect Focused Exome
9 F 7 7 CHD 0.43 Chronic cough SI 33 10.9 Normal ciliary beat pattern Normal ND CM Watson et al. 2014
10 M 10 <1 Sib 11 & 12 −1.32 Neonatal respiratory distress, nasal discharge SI 26 11.5
Mixed: Normal areas, 
immotile areas, dyskinetic 
areas
Normal Normal Illumina TruSeq custom gene panel
11 F 21 10 Sib 10 & 12 ND
Recurrent chest infections, asthma, 
persistent collapse of right lower 
lobe
SI 293 8.5 Mixed: Mostly reduced forward and recovery stroke IDA Normal Illumina TruSeq custom gene panel
12 M 13 <1 Sib 10 &11 −1.24 Neonatal respiratory distress, nasal discharge SS 214 16.3 Normal ciliary beat pattern IDA Normal Illumina TruSeq custom gene panel
13 F 29 29 No ND Bronchiectasis, infertility SI 239 4.31
Mixed: Mostly reduced 
forward and recovery stroke. 
Static patches
Normal Insufficient Agilent SureSelectXT Ciliome_651
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Demographics Symptoms Diagnostic test results
ID Sex Age (yrs) Age diag (yrs) Family History FEV1 z-score Main Symptoms Situs Nasal NO (nl/min) CBF (Hz) Ciliary beat pattern
Electron 
microscopy 
(1st 
brushing)
Electron 
microscopy 
(repeat 
brushing)
Genetics: sequencing protocol
14 F 1 1 No ND Neonatal respiratory distress, nasal discharge, wet cough SI ND 16.76 Dyskinesia Normal Inconclusive Agilent SureSelectXT Ciliome_651
15 F 21 21 Sib 16 ND
Recurrent chest infections in 
childhood. No ear, chest or nasal 
symptoms in adulthood
SI 151 10.9 Normal ciliary beat pattern IDA Normal Agilent SureSelectXT Ciliome_651
16 M 18 18 Sib 15 ND
Sensory neural hearing 
impairment, recurrent chest 
infections, chronic nasal 
congestion and rhinitis
SI 276 9.9
Mixed. 80% normal ciliary 
beat pattern. 20% immotile 
cilia on strips.
IDA Normal Agilent SureSelectXT Ciliome_651
Normal test results are highlighted in bold. Age diag, age diagnosis confirmed; SI, situs inversus; SS, situs solitus; NO, nitric oxide; CBF, ciliary beat frequency; IDA, inner dynein arm; ODA, outer dynein arm; ND, not done.
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Table 2
Comparison of mean values of clinical tests obtain in CCDC103 p.His154Pro cases versus a comparator group
Clinical features N CCDC103 p.His154Pro N Comparator group
Age (mean SD) 16 11.8 (4.8) 16 11.9 (8.8)
Gender (% Male) 16 67% 16 63%
Nasal Nitric Oxide (nl/min) 14 63 (63) 9 12 (7)**
Ciliary beat frequency (Hz) 16 7.5 (4.7) 16 1.3 (3.6)**
Proportion of IDA absent on TEM 15 46% 16 63%
Proportion of ODA absent on TEM 15 27% 16 89%**
FEV1 z score (median IQR) 10 −1.4 (−0.8, −2.1) 13 −1.8 (−1.5, −2.1)
Situs Inversus 16 81% 16 56%
The CCDC103 p.His154Pro cases are described in Table 1 and the comparator group are South Asian origin CCDC103 p.His154Pro-negative cases with a confirmed absent dynein arms defect. Data shown 
as the mean, with standard deviation shown in brackets (StDev).
**p<0.005.
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